Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX1 | Q9Y5S8 | 9/20 | 0.59 |
| ▸ | MAPT | P10636 | 7/20 | 0.59 |
| ▸ | GAA | P10253 | 6/20 | 0.59 |
| ▸ | BCHE | P06276 | 2/20 | 0.59 |
| ▸ | ACHE | P22303 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | SNCA | P37840 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.59 |
| ▸ | MAOA | P21397 | 1/20 | 0.59 |
| ▸ | CNR1 | P21554 | 1/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.59 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.59 |
| ▸ | HTR2C | P28335 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29384027 | 1.00 | NOX1 (0.59) | NOX1MAPTGAABCHEACHE | |
| Water SCHEMBL3136465 | 0.98 | NOX1 (0.57) | NOX1MAPTGAABCHEACHE | |
| SCHEMBL12003759 | 0.98 | NOX1 (0.57) | NOX1MAPTGAABCHEACHE | |
| SCHEMBL12273297 | 0.86 | BCHE (0.41) | NOX1MAPTGAABCHEACHE | |
| SCHEMBL30274184 | 0.82 | NOX1 (0.67) | NOX1MAPTGAABCHEACHE | |
| SCHEMBL10530491 | 0.82 | NOX1 (0.67) | NOX1MAPTGAABCHEACHE | |
| SCHEMBL28373803 | 0.81 | NOX1 (0.55) | NOX1MAPTGAABCHEACHE | |
| SCHEMBL28796458 | 0.80 | NOX1 (0.53) | NOX1MAPTGAABCHEACHE | |
| SCHEMBL20424966 | 0.80 | SNCA (0.46) | NOX1MAPTGAABCHEACHE | |
| SCHEMBL194062 | 0.78 | NOX1 (0.61) | NOX1MAPTGAABCHEACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114084877-B | Method for obtaining ultrapure ferric phosphate from waste lithium iron phosphate pole piece material and obtained ultrapure ferric phosphate | 长沙理工大学 | 2024-01-16 | — | — | CN | claimed |
| CN-114084877-A | Method for obtaining ultrapure iron phosphate from waste lithium iron phosphate electrode plate material and obtained ultrapure iron phosphate | 长沙理工大学 | 2022-02-25 | — | — | CN | claimed |
| EP-4326729-B1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2025-06-04 | — | — | EP | disclosed |
| CN-115537853-B | Direct electrochemical synthesis method of triarylamine compound | 浙江工业大学 | 2025-01-10 | — | — | CN | disclosed |
| US-20250011261-A1 | METHOD FOR PRODUCING HEXAFLUORO-1,3-BUTADIENE | RESONAC CORPORATION (JP) | 2025-01-09 | — | — | US | disclosed |
| US-20240224802-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO LTD (KR) | 2024-07-04 | — | — | US | disclosed |
| CN-118055914-A | Process for producing hexafluoro-1, 3-butadiene | 株式会社力森诺科 | 2024-05-17 | — | — | CN | disclosed |
| EP-4326729-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | Samsung Display Co., Ltd. (KR) | 2024-02-28 | — | — | EP | disclosed |
| CN-114084877-B | Method for obtaining ultrapure ferric phosphate from waste lithium iron phosphate pole piece material and obtained ultrapure ferric phosphate | 长沙理工大学 | 2024-01-16 | — | — | CN | disclosed |
| CN-117203213-A | Organic molecules for optoelectronic devices | 三星显示有限公司 | 2023-12-08 | — | — | CN | disclosed |
| EP-4196464-A1 | PROTEASOME ENHANCERS AND USES THEREOF | Board Of Trustees Of Michigan State University (US) | 2023-06-21 | — | — | EP | disclosed |
| CN-1980658-A | Treatment of diseases using ICE inhibitors | VERTEX PHARMA (US) | 2007-06-13 | — | — | CN | disclosed |
| CN-1964716-A | Isoquinoline derivatives and methods of use thereof | INOTEK PHARMACEUTICALS CORP (US) | 2007-05-16 | — | — | CN | disclosed |
| CN-1693879-A | Method and kit for investigating humotype semi-cystinol by enzyme biochemical reaction | ZHEJIANG YAKE PHARMACEUTICAL C (CN) | 2005-11-09 | — | — | CN | disclosed |
| CN-1284075-A | Novel compounds having CGMP-PDE inhibitory effect | MOCHIDA PHARM CO LTD (JP) | 2001-02-14 | — | — | CN | disclosed |
| CN-1103315-A | Improved methods for the determination and adjustment of prolactin daily rhythms | UNIV LOUISIANA STATE (US) | 1995-06-07 | — | — | CN | disclosed |
| US-5391465-A | Using phenothiazine or phenoxazine compounds | ROHM AND HAAS COMPANY (US) | 1995-02-21 | — | — | US | disclosed |
| EP-0404499-A2 | Photosensitive compositions comprising selected photoactive materials and their use in producing high resolution, photoresist images with near ultraviolet radiation | ROHM AND HAAS COMPANY (US) | 1990-12-27 | — | — | EP | disclosed |
| CN-1006386-B | PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER | SHINETSU CHEM IND CO (JP) | 1990-01-10 | — | — | CN | disclosed |
| CN-85107531-A | Process for producing vinyl chloride polymer | — | 1987-01-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240224802-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | OR10J3, ORC3, NOX3 | NOX1 39/4885MAPT 4643/4885GAA 4878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.